Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study

Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study

It is unknown whether neurological symptoms are associated with brain injury after SARS-CoV-2 infections and whether brain injury and related symptoms also emerge in Long-COVID patients. Biomarkers such as serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) can be used...

Full description

Bibliographic Details
Main Authors: Julia Telser, Kirsten Grossmann, Ornella C. Weideli, Dorothea Hillmann, Stefanie Aeschbacher, Niklas Wohlwend, Laura Velez, Jens Kuhle, Aleksandra Maleska, Pascal Benkert, Corina Risch, David Conen, Martin Risch, Lorenz Risch
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Diagnostics
Subjects:
COVID-19
SARS-CoV-2
serum biomarker
glial fibrillary acidic protein
neurofilament light chain
GFAP
Online Access:https://www.mdpi.com/2075-4418/13/13/2167

Internet

https://www.mdpi.com/2075-4418/13/13/2167

Similar Items